" class="no-js "lang="en-US"> Sunghoon Kwon - Medtech Alert
Saturday, June 22, 2024
Sunghoon Kwon

Sunghoon Kwon

About Sunghoon Kwon

Sunghoon Kwon earned his PhD in Bioengineering from University California at Berkeley, California, USA in 2004. After a postdoctoral fellowship at Lawrence Berkeley National Laboratory, he was appointed to his current role as a Professor at the Department of Electrical Engineering at Seoul National University.

In recognition of his outstanding achievements, Dr. Kwon has received numerous awards, including Young Scientist Award from The Korean Academy of Science and Technology (2011), Young Scientist Award from the Korean President (2012), “IT Young Engineer Award” from IEEE (2016), Young Engineer Award from National Academy of Engineering of Korea (2018). He has authored more than 70 peer-reviewed publications and has served as Advisory Board member of Lab on a Chip since 2017. Another major contribution by Professor Kwon is the commercialization of his microfluidic technologies. A rapid antibiotic susceptibility testing method published in Lab on a Chip (2013) and Science Translational Medicine (2014) and a high-throughput DNA synthesis method (Nature Communications 2015) has been commercialized by two companies, QuantaMatrix.Inc and Celemics.Inc, which were spun off Professor Kwon’s laboratory. He currently is a CEO of QuantaMatrix and an advisory board member of Celemics.

His research interests are the interface of biomedical engineering, bioMEMS, optofluidics, nanofabrication, and nanoengineering, specifically focusing on innovative diagnostic and synthetic biology platforms for personalized medicine.

Related Story

Limbach Group Adopts QuantaMatrix dRASTTM in Routine Clinical Use

December 15 2021

QuantaMatrix, an in vitro diagnostics company specializing in the discovery, development and commercialization of fully-integrated solutions within […]